Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when BIO-TECHNE Corp publishes a filing, an earnings call transcript or a press release.

Get TECH alerts

About David Eansor

The proxy statement of BIO-TECHNE Corp reports total compensation of $3,209,406 for David Eansor in fiscal 2022, including a base salary of $448,141. Disclosed compensation is on record for 5 fiscal years. BIO-TECHNE Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BIO-TECHNE Corp includes Charles Kummeth (CEO), James T. Hippel (CFO), Kim Kelderman (COO and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at BIO-TECHNE Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 BIO-TECHNE Corp (TECH) $448,141 $3,209,406
2021 BIO-TECHNE Corp (TECH) $585,000 $6,438,528
2020 BIO-TECHNE Corp (TECH) $552,000 $2,685,749
2019 BIO-TECHNE Corp (TECH) $501,380 $2,323,038
2018 BIO-TECHNE Corp (TECH) $455,000 $1,591,282

Recent activity

No call appearances or filed executive changes recorded yet.